Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience

Real-world predictors of the treatment efficacy of immune checkpoint inhibitors for hepatocellular carcinoma (HCC) are unknown. This retrospective study enrolled 87 consecutive patients with unresectable HCC from May 2017 to December 2019 at two hospitals. Of the 87 patients, 7, 9, 60, and 11 patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Hsu, Wei-Fan, Chuang, Po-Heng, Chen, Cheng-Kuo, Wang, Hung-Wei, Tsai, Ming-Hung, Su, Wen-Pang, Chen, Hung-Yao, Yang, Chi-Ying, Lin, Chun-Che, Huang, Guan-Tarn, Lin, Jaw-Town, Lai, Hsueh-Chou, Peng, Cheng-Yuan
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783753/
https://ncbi.nlm.nih.gov/pubmed/33415018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars